The incidence of Candida urinary tract infections is gradually on the rise and is an important public health problem. The aim of our study was to determine the prevalence of urinary tract candidiasis (candiduria) in HIV positive patients in Dschang District Hospital and the antifungal susceptibility test of isolates. A total of 285 patients were recruited for this study. Midstream urine samples were collected and processed using standard mycological techniques. Candida isolates were identified base on the colony color on CHROMagar. Antifungal susceptibility testing of the isolates was performed by the broth dilution method using four commonly used antifungals. Results showed that 22% of patients had Candida spp in their urine. Candida albicans had a proportion of 37% against 63% for non-albicans Candida. Of the 53 isolates tested, ketoconazole had the highest percentage of resistance (88.6%) follow by fluconazole (64.1.6%), amphotericin B (56.6%) and nystatin (49.0%). The highest sensitivity was observed with nystatin (33.9%) while the lowest was found with ketoconazole (5.6%). In conclusion, the prevalence of candiduria among HIV positive patients in this study was 22%. Candida albicans remain the most frequently involved Candida species. Azole antifungals showed the highest resistance rate against all the Candida species isolates.
INTRODUCTION
Candidiasis is a common opportunistic infection in HIV-infected patients (Kauffman, 2014) . The spectrum of Candida infection is diverse, starting from asymptomatic colonization to pathogenic forms. The low absolute CD4+ T-lymphocyte count has traditionally been cited as the greatest risk factor for the development of oropharyngeal candidiasis and current guidelines suggest increased risk once CD4+ T lymphocyte counts fall below 200 cells/µL (Anwar et al., 2012) . Candiduria presents as an increasingly common nosocomial infection, which may involves urinary tract. Spectrum of disease is varying from asymptomatic candiduria to clinical sepsis. Several reports showed that the frequency of urinary tract infection due to yeasts has increased during the last decade (Yashavanth et al., 2013) . Changes in the clinical severity of candidiasis and the Candida species prevalence profile may be a reflection of immunological changes in HIV positive patients. Though Candida albicans is the most frequently isolated species as a colonizer and pathogen of mucosa, other Candida species, such as C. tropicalis, C. krusei, C. glabrata, C. dubliniensis, C. guilliermondii, C. parapsilosis, C. kefyr, and C. pelliculosa, have become a significant cause of infection in patients with HIV infection (Fusi et al., 2011; Kaur et al., 2016) . The clinical importance of these non-albicans Candida species lies in the fact that they are usually less susceptible to the more commonly used azole antifungal drugs, a factor that poses significant difficulties in effective treatment (Maheshwari et al., 2016) . During the last few decades, the spectrum of infections has undergone a drastic change; organisms with minimal or no pathogenic role have emerged as potent pathogens and organisms once susceptible have become multidrug resistant (Ojieabu et al., 2012; Seifi et al., 2013) . Emergence of non-albicans Candida species as a cause of refractory candidiasis, particularly in patients with advanced immunosuppression and problem of resistance to azoles and other antifungal agents in the Candida species is a point of concern (Lozes et al., 2012; Deorukhkar et al., 2014) . Therefore, this variability in the behaviour of different Candida spp. and the increasing number of clinical isolates resistant to current antifungal therapies highlight the need for antifungal susceptibility testing to monitor the antifungal resistance of these microorganisms. The modern mycologist has an important role to play in several aspects relating to these organisms, including detection, identification, epidemiological analysis, and therapy in an attempt to better understand these pathogens and provide an effective cure (Maheshwari et al., 2016) . This could guide the therapeutic choice and the clinical treatment (Terças et al., 2017) . The overall prevalence of urinary candidiasis among HIV infected patients was found to be 18.8% and 36.2% in two localities of Cameroon, Buea and Yaounde respectively (Lohoué et al., 2005; Longdoh et al., 2013) . However, in the west region of Cameroon, candiduria in HIV infected patients is not looking for in general practice. Yet it can be the source of disseminated infection in immunosuppressed individuals. The aim of the present study was to determine the frequency of candiduria in HIV positive patients in Dschang District hospital and to determine the susceptibility to antifungal drugs of Candida species isolated in the view to contributing to a better management of Candida infections in HIV+ patients.
MATERIALS AND METHODS

Study population
This study was a cross-sectional study carried out during a period of 9 months, from June 2013 to February 2014 at the Dschang District Hospital. After the aim of research was clearly explained to the patients who fulfill the included criteria, patients gave written consent. The study was conducted in accordance with the declaration of Helsinki, and the protocol was approved by the Cameroon Bioethics Initiative Ethics Review and Consultancy Committee (CAMBIN ERRC) and an ethics clearance with reference number CBI/297/ERCC/CAMBIN was issued.
Sample collection and culture
The urine samples were collected from patients and were processed for yeasts at the laboratory of Microbiology and Antimicrobial substances of the Biochemistry Department, University of Dschang. None of the patients used antifungal during the sampling. After cleaning the genital region with a dakin solution (antiseptic), midstream urine were collected from patients into sterile urine bottles in the morning and maintained at 4 °C during transportation to the laboratory for analysis. 100 µl of each uncentrifuged urine sample was cultured on CHROMagar Candida (CHROMagar Candida®) containing chloramphenicol plates as lawn and incubated at 25 °C for 48 h. Yeasts were identified to the species level by standard methods: microscopic morphology, characteristic color displayed on CHROMagar.
Antifungal susceptibility testing
The sensitivity of obtained isolates was tested vis-a-vis of four antifungal namely: fluconazole, nystatin, amphotericin B and ketoconazole. The minimum inhibitory concentration (MIC) of the antifungal were determined by liquid medium microdilution technique according to the protocol described by the National Committee and Clinical Laboratory Standard (NCCLS, 2002 (Thérèse et al., 2006) 
RESULTS
Our study population was made up of 285 patients of which 224 women (79%) and 61 men (21%) with a sex ratio of 3.7 in favor of the women. The average of global age of patients was 39.69 ± 11 years with extremes of 4 years (minimum) and 69 years (maximum). In this population, 4% (11) were children (0-20), 78% (223) were young adults (21-49 years) and 18% (21) of more than 50 years (Table 1) .
Five different Candida species were identified namely C. albicans, C. glabrata, C. krusei C. dubliniensis and C. tropicalis (Figure 1 ). The most prevalent species was C. albicans 37.5% followed by C. glabrata 19.4%, C. krusei, 16.6%, C. tropicalis 11.1% and C. dubliniensis 8.3%. There was 6.9% of non-identified species. It is noteworthy that non-albicans Candida species emerged with 55.4% against 37.5% for Candida albicans species (Figure 1) .
Among the 224 women, 21% were positive to candiduria while 6% of 64 men were positive to candiduria. Therefore, women were more affected by candiduria than men. Regarding the age groups, 21 to 49 range was the most affected 22% (48/223), follow by the ≥50 age in which 19% of person were affected (4/11). About CD4+ level, 42% had 201-500 count/ mm 3 followed by patients with CD4+ ≤200 (31%) ( Table 2 ). There was an unequal distribution of the Candida species in the two sexes, with a predominance of all the species among women, except Candida dubliniensis which was predominant in men. The age range of 21-49 years was the age groups where all Candida species were the most represented, particularly Candida dubliniensis followed by Candida albicans and Candida glabrata. Patients with 201-500 counts/mm 3 CD4+ level were the most affected by candiduria ( Table 2) . The results of the antifungal susceptibility test showed a wide range of MIC value varying from <0.125 µg/mL to >256 µg/mL with the smallest geometric mean of <0.54 µg/mL. Regarding the range of inhibitory concentration and geometric mean, nystatin had the smallest range and geometric mean values for all isolates follow by amphotericin B (Table 3 ). All the Candida albicans species were resistant to nystatin and ketoconazole. Ketoconazole had the highest percentage of resistance towards Candida spp isolates (88.6%), follow by fluconazole (64.1.6%), amphotericin B (56.6%) and nystatin (49.0%). The highest sensitivity was observed with nystatin (33.9%) while the lowest was found with ketoconazole (5.6%) ( Table 4 ). is more implication of non-albicans Candida in fungal infection (Fleming et al., 2002) . The results of the prevalence of etiologic agents of candiduria in this study showed that nonalbicans Candida represented 55.7% against 37.5% for Candida albicans species, confirming the tendency of the general increase prevalence of non-albicans Candida in candidiasis (Abi-Said et al., 1997; Fleming et al., 2002) . This study included 224 women (79%) and 61 men (21%) giving a sex ratio of 3.7 in favor of the women. Women are more exposed to infections than men, especially through their surface genital area and greater exposure. Esebelahie et al. (2013) previously reported the female gender as a significant risk factor for acquiring Candida infection in asymptomatic HIV patients attending a tertiary hospital in Benin City in Nigeria. In addition, the hormonal differences that exist between, the levels of estrogen and progesterone that are reduced in men could also explain this result. Indeed, Candida albicans has membrane receptors that bind progesterone colonization (Zlotnik et al., 2011) . The distribution of HIV infected patients by age reported a mean overall age of 39.69 ± 11 years with a predominance of young adults. We also noticed a high prevalence of candiduria (92%) among young adults. These results corroborate with those of Lohoué et al. (1991) ). These findings are similar observation previously made by Longdoh et al. (2013) who reported that urinary candidiasis was more frequent in individuals with CD4+ T cell count below 200 cells/µL.
Treatment against candidiasis varies substantially depending on the anatomical localization of the infection, the immune status of the patient, and the isolated species (Rex et al., 2000) . In order to understand the therapeutic differences in the isolates involved in candiduria study population, we tested the sensitivity of these isolates. Our findings indicated that Candida albicans isolates were highly resistant to ketoconazole and nystatin.
Among non-albicans Candida species high resistance was observed with ketoconazole against Candida tropicalis. These results can be compared with those of Sangeorzan et al. (1994) shown that, Candida albicans and nonalbicans Candida species differ from one to another in their epidemiology, virulence and susceptibility to antifungals, verification of specific implication of each species of Candida is required before any therapeutic decision (Rex et al., 2000) .
Conclusion
The present study reiterates the prevalence of candiduria species among HIV positive patients in Dschang District hospital and their antifungal susceptibility pattern of Candida spp involved. The prevalence of candidiasis among HIV patients in this study was 22%. Candida albicans remain the most frequently involved Candida species. Azole antifungals showed the highest resistance rate against all the Candida species isolates. Therefore, the species identification of Candida isolates along with their antifungal susceptibility pattern can help the clinicians in better treating the patients with candiduria.
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